ORPP logo

HDL and LDL Cholesterol : (Record no. 59756)

MARC details
000 -LEADER
fixed length control field 05370nam a22005053i 4500
001 - CONTROL NUMBER
control field EBC3018574
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729124104.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240724s2009 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781608767281
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781607417675
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC3018574
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL3018574
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10660435
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)923658905
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QP99.3.L52 -- H45 2009eb
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 572/.68
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pagano, Irwin S.
245 10 - TITLE STATEMENT
Title HDL and LDL Cholesterol :
Remainder of title Physiology and Clinical Significance.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Nova Science Publishers, Incorporated,
Date of production, publication, distribution, manufacture, or copyright notice 2009.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2009.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (242 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Biochemistry Research Trends
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Intro -- HDL and LDL Cholesterol: Physiology and Clinical Significance -- Contents -- Preface -- Cost-Effectiveness of Pharmacological Therapies to Reduce LDL-Cholesterol Levels -- Abstract -- Introduction -- Recommendations for Cholesterol-Lowering Therapies -- Cholesterol-Lowering Drugs -- Cost-Effectiveness of Secondary Prevention of CHD with Cholesterol-Lowering Drugs -- Cost-Effectiveness of Primary Prevention of CHD with Cholesterol-Lowering Drugs -- Cost-Effectiveness of Statins to Reduce LDL-Cholesterol and Achieve ATP-III Objectives -- Conclusion -- References -- Mechanisms for Oxidative Modification of LDL by Cigarette Smoking: New Insight into Potential Implications for Atherosclerosis -- Abstract -- 1. Introduction -- 2. Development of Assay Methods of Modified LDL -- 3. Evidence of Modified LDL in the Plasma by CSE -- 4. Evidence of Peroxynitrite-Generating Species in CSE -- 6. Conclusion -- References -- Selective LDL Apheresis Reduced on Plasma Concentrations of Adhesion Molecules -- Abstract -- Introduction -- Patients and Methods -- Results -- Discussion -- References -- Pleiotropic Effects of Atorvastatin on Vascular Injury in Diabetes -- Abstract -- Introduction -- Effects of Atorvastatin on Diabetic Retinopathy -- Effects of Atorvastatin on Diabetic Nephropathy -- Effects of Atorvastatin on CVD in Diabetes -- Possible Molecular Mechanisms by which Atorvastatin Exerted Beneficial Effects on Vascular Injury in Diabetes -- Conclusion -- References -- Antibodies to Oxidatively Modified LDL and Atherosclerosis -- Abstract -- Introduction -- Measures of "Auto"Antibodies to OxLDL -- Clinical Studies -- Conclusion -- References.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Overview of Longevity-Associated Mitochondrial DNA 5178 C/A Polymorphism and a Discussion of its Modulation of the Effects of Habitual Smoking on Serum Total and LDL Cholesterol Levels in Middle-Aged Japanese Men -- Abstract -- Introduction -- Subjects and Methods -- Results -- Discussion -- Acknowledgments -- References -- Cholesterol-HDL Levels and Functionality of the HDL Particle, Its Anti-Inflammatory/Antioxidant Properties -- Abstract -- Introduction -- HDL Cholesterol Levels and Quality of the HDL Particle -- Genetic Traits Related with the HDL Particle and their Relationship with Cardiovascular Disease -- Conclusion -- Acknowledgment -- References -- The Role of HDL-Associated Enzymes in Bovine Reproduction -- Abstract -- Introduction -- Relationship between Negative Energy Balance and Reproduction -- Oxidative Stress in Dairy Cows -- Anti-Oxidative and Anti-Inflammatory Properties of HDL -- Conclusion -- References -- HDL Physicochemical Characteristics as Determinants of Their Plasma Concentrations: What We Have Learned from Thiazolidinediones -- Abstract -- Introduction -- HDL Metabolism -- Apolipoproteins as Determinants of HDL Metabolism -- Lipids and HDL Metabolism: Possible Contribution of the Surface Electric Charge -- HDL Size as Determinant of Their Catabolism -- PPAR Activation and HDL Metabolism -- Conclusion -- Acknowledgments -- References -- High-Density Lipoproteins and Coronary Heart Disease HDLs: A Heterogeneous and Multi-Functional Lipoprotein Class -- Abstract -- Introduction -- HDL Heterogeneity -- Formation and Remodeling of HDL -- The Role of HDL in CHD -- Low HDL as a Risk Factor and a Therapeutic Target -- HDL-Related Therapy -- References -- Index.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element High density lipoproteins -- Physiological effect.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element High density lipoproteins -- Pathophysiology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Low density lipoproteins -- Physiological effect.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Low density lipoproteins -- Pathophysiology.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Strait, Nathan B.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Pagano, Irwin S.
Title HDL and LDL Cholesterol
Place, publisher, and date of publication New York : Nova Science Publishers, Incorporated,c2009
International Standard Book Number 9781607417675
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Biochemistry Research Trends
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018574">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018574</a>
Public note Click to View

No items available.

© 2024 Resource Centre. All rights reserved.